Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-15

Clinical Trial Update: Study Comparing Glycerin With 1% Lidocaine and Epinephrine Versus Glycerin With 1% Lidocaine Without Epinephrine for the Sclerotherapy of Leg Telangiectasias [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing two glycerin-based sclerotherapy formulations — one with lidocaine and epinephrine and one with lidocaine without epinephrine — for le…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glycerin with lidocaine and epinephrine for sclerotherapy (glycerin; lidocaine; epinephrine)
  • Glycerin with lidocaine without epinephrine for sclerotherapy (glycerin; lidocaine)

Snippet

Sponsor: Goldman, Butterwick, Fitzpatrick and Groff | Conditions: Leg Veins | Phase 4 | Status: NOT_YET_RECRUITING